The humoral immune response to HCV: understanding is key to vaccine development
Hepatitis C virus (HCV) remains a global problem despite advances in treatment. The low cost and high benefit of vaccines have made them the backbone of modern public health strategies, and the fight against HCV will not be won without an effective vaccine. Achievement of this goal will benefit from...
Main Authors: | Siobhán B Cashman, Brian D. Marsden, Lynn B Dustin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00550/full |
Similar Items
-
Prevalence of Hepatitis C Virus (HCV) Genotypes in Rawalpindi and Islamabad Region
by: Andleeb Afzal
Published: (2017-06-01) -
Seroprevalence of isolated HBV, HBV and HCV Co - infection at MRIMS, Hyderabad
by: Grishma Kulkarni
Published: (2014-01-01) -
Most common HCV genotypes in patients from north-eastern Croatia
by: Magdalena Perić, et al.
Published: (2014-05-01) -
Performance characteristics of a combined hepatitis C virus core antigen and anti–hepatitis C virus antibody test in different patient groups
by: Jeng-Fu Yang, et al.
Published: (2011-07-01) -
Hepatitis C virus vaccine design: focus on the humoral immune response
by: Daniel Sepulveda-Crespo, et al.
Published: (2020-07-01)